Replies to post #2724 on Ariad Pharmaceuticals Inc fka ARIA

[biotech_researcher]

Don, what is your take away on:

EN.8 - A PHASE III STUDY OF STANDARD THERAPY VERSUS RIDAFOROLIMUS IN WOMEN WITH RECURRENT OR METASTATIC ENDOMETRIAL CANCER WHO HAVE PREVIOUS HAD CHEMOTHERAPY

Thanks.

BTR

[JJM760]

I didn't get a chance to review the presentation. Was the data the same/better/worse as the abstract you posted here last month?

This endo find was your baby so I ask you what you think now.

Thanks